Approved Enterprise Formulary
FormWeb QuickStart Questions or Suggestions? Pharmacy Shared Services Center
Show Therapeutic Classes
Hazardous Drugs
QR Code Add Formweb to your mobile device
Android iOS
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Approved Enterprise Formulary
FormWeb QuickStart Questions or Suggestions? Pharmacy Shared Services Center
Search results for:

riTUXimab

riTUXimab
Drug Name Form Strength Ambulatory Use Only Ambulatory Restrictions Inpatient Restrictions Non-Formulary
Riabni SOLUTION, INTRAVENOUS arrx 10 mg/mL      
Ruxience SOLUTION, INTRAVENOUS pvvr 10 mg/mL      
Rituxan SOLUTION, INTRAVENOUS 10 mg/mL      
VIEW MORE antineoplastics, miscellaneous agents, antirheumatics, CD20 monoclonal antibodies
  Generic Name Brand Name
Biosimilar (HFH preferred) rituximab-pvvr Ruxience
Biosimilar (approved alternate)* rituximab-arrx Riabni
Originator product rituximab Rituxan

*Alternate biosimilar approved for ambulatory clinics when HFH preferred rituximab biosimilar (Ruxience) not covered by insurance.

Last updated: Aug. 21, 2026
UpToDate Lexidrug






This site is intended for the staff of Henry Ford Health.
While others may view accessible pages, Henry Ford Health makes no warranty, express or implied,
as to the use of this information outside of Henry Ford Health.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved